View Older Stories View More Recent Stories
-
FedEx (FDX) PT Lowered to $276 at Goldman Sachs
-
CFRA Downgrades FedEx (FDX) to Sell
-
BofA cuts UPS, FedEx ratings, citing de minimis volume and cost pressures
-
BofA Securities Downgrades FedEx (FDX) to Neutral
-
FedEx (FDX) PT Lowered to $285 at JPMorgan
-
FedEx (FDX) PT Lowered to $293 at UBS on Softer Volume Trend
-
DBS Group Upgrades FedEx (FDX) to Buy
-
FedEx (FDX) files for two-parts euro-notes offering
-
FedEx (FDX) option IV near lower end of range
-
FedEx (FDX) Announces Resignation of Chief Digital and Information Officer and Chief Transformation Officer Sriram Krishnasamy
-
FedEx (FDX) PT Lowered to $297 at UBS
-
FedEx (FDX) PT Lowered to $249 at Evercore ISI after earnings
-
JPMorgan Reiterates Overweight Rating on FedEx (FDX)
-
FedEx (FDX) PT Lowered to $245 at BofA Securities
-
FedEx (FDX) PT Lowered to $269 at TD Cowen
-
FedEx (FDX) PT Raised to $235 at Wells Fargo
-
Stocks expected to have increasing option volume: FDX UPS NKE LULU GIS PAYX XPO
-
FedEx (FDX) PT Lowered to $260 at Raymond James
-
Truist Securities Reiterates Buy Rating on FedEx (FDX)
-
FedEx (FDX) PT Lowered to $259 at Citi
-
FedEx (FDX) Tops Q4 EPS by 11c, Beats on Revenue; Offers Guidance
-
Analysts hold ‘low expectations’ for this delivery giant ahead of its earnings
-
FedEx (FDX) call put ratio 1 calls to 1 put into quarter results
-
FedEx (FDX) PT Lowered to $329 at Stifel
-
FedEx (FDX) call put ratio 1 call to 1 put into quarter results
-
FedEx (FDX) call put ratio 1 calls to 1 put into quarter results
-
UBS Reiterates Buy Rating on FedEx (FDX)
-
FedEx (FDX) PT Lowered to $259 at Evercore ISI
-
FedEx (FDX) call put ratio 1.9 calls to 1 put into quarter results
-
FedEx (FDX) suspends pickups for shipments to Iraq and Israel
-
FedEx (FDX) PT Lowered to $280 at Stephens
-
FedEx (FDX) PT Lowered to $249 at Bernstein SocGen Group
-
FedEx (FDX) PT Lowered to $253 at Wolfe Research
-
FedEx (FDX) Raises Quarterly Dividend 5.1% to $1.45; 2.6% Yield
-
FedEx Global Healthcare Secures IATA CEIV Pharma Corporate Certificate
-
Truist Recommends Investors 'Build Positions' in FedEx (FDX) Ahead of Freight Spin
-
FedEx (FDX) PT Lowered to $260 at JPMorgan
-
Avoid owning this popular shipping stock ahead of upcoming earnings report: analyst
-
FedEx (FDX) PT Lowered to $311 at UBS
-
FedEx (FDX) Global Healthcare Secures IATA CEIV Pharma Corporate Certificate
-
UBS Reiterates Buy Rating on FedEx (FDX)
-
FedEx (FDX) Announces Leadership for Independent FedEx Freight Company Upon Separation
-
FedEx (FDX) PT Lowered to $260 at BMO Capital Amid 'Persistent Demand Headwinds'
-
FedEx (FDX) Estimates, PT Lowered to $260 at BMO Capital
-
Bernstein Reiterates Market Perform Rating on FedEx (FDX) Following Investor Webcast
-
FedEx (FDX) PT Lowered to $270 at BofA Securities
-
Amazon (AMZN) strikes a new partnership with FedEx (FDX) after UPS (UPS) pullback - Business Insider
-
FedEx (FDX) Announces Resignation of David P. Steiner from Board
-
Wells Fargo lowers parcel estimates, UPS stock downgraded
-
FedEx (FDX) call put ratio 1 call to 1.4 puts as share price down 5.9%

